The global nitric oxide synthase brain market is anticipated to grow at a significant CAGR during the forecast period. Nitric oxide synthases are group of enzymes that convert L-arginine to L-citrulline and produce nitric oxide. Nitric oxide synthases enzymes exhibit a bidomain structure homologous to cytochrome P450 reductase. According to a study in 2015 by NCBI, nitric oxide is a potential approach for preserving the structural and functional integrity of the brain. The market is growing as several studies are focused on analysing the use of nitric oxide as a treatment approach for different brain related disorders such as brain injuries, brain ischemia, memory disorders and neurotoxicity. Additionally, the increasing prevalence of brain related disease is expected to boost the demand of nitric oxide products and helping to drive the growth of the global nitric oxide synthase brain market. For instance, according to a data published by the Centres for Disease Control and Prevention in 2017, around 153 people in the U.S. die from injuries that include traumatic brain injury, every day and accounts for around 30% of all injury-related deaths.
Impact of COVID-19 Pandemic on Global Nitric Oxide Synthase Brain Market
During the outbreak of COVID-19, WHO declared it as a public health emergency globally. All the major operations and research were postponed due to COVID-19. Hospitals were more focused in treating COVID-19 patients and the effect was also felt in the nitric oxide synthase brain market. However, the government regulatory are changing and the global nitric oxide synthase market is anticipated to recover in the forecast period.
Segmental Outlook
The global nitric oxide synthase brain market is segmented based on the type and application. Based on the type, the market is segmented into NNOS, ENOS, and INOS. Amongst the type, NNOS is anticipated to propel the growth of the market over the forecast period. Based on the end-user, the market is sub-segmented into research institute, biotechnology, pharmaceutical company, and others. Amongst the end-user, the pharmaceutical company using nitric oxide synthase brain market is anticipated to grow more in the forecasted period. The above-mentioned segments can be customized as per the requirements.
Global Nitric Oxide Synthase Brain Market Share by Type, 2022 (%)
The NNOS is Anticipated to Hold a Prominent Share in the Global Nitric Oxide Synthase Brain Market
The NNOS market is anticipated to hold the major share in the global nitric oxide synthase brain market. This is because in the central nervous system, NNOS produces nitric oxide that has been implicated in modulating physiological functions such as synaptic plasticity, learning, memory and neurogenesis. It also have some pathological utilities where overproduction of nitric oxide may lead to the highly reactive species such as peroxynitrite and stable nitrosothiols, which may cause irreversible cell damage in excitotoxicity, ischaemia, Parkinson, Alzheimer's disease (AD) and depression. NNOS also involves in the blood pressure regulation, smooth muscle relaxation, and vasodilatation. The neuronal nitric oxide synthase brain market is anticipated to hold the major share in the forecast period.
Regional Outlooks
The global nitric oxide synthase brain market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The North American nitric oxide synthase brain market is expected to hold prominent share in the global nitric oxide synthase brain market.
Global Nitric Oxide Synthase Brain Market Growth, by Region 2022-2028
The North America Region is estimated to Hold the Major Share in the Global Nitric Oxide Synthase Brain Market
North America is anticipated to hold the major share in the global nitric oxide synthase brain market. This region hold a prominent share in the market owing to the presence of major players in the region such as Enzo Life Science Inc., Bio-Rad Laboratories, among others. They offer a wide range of NOS products for brain-related disorders. An estimation of 1.2 million people aged and older are diagnosed with brain disorder annually in US. The rising prevalence of the brain related disorder in North America is boosting up the global nitric oxide synthase brain market.
Market Players Outlook
The major companies serving the global nitric oxide synthase brain market include Abbexa, Bio-Rad Laboratories, Inc., Bioss, Biovision Inc., Merck KGaA, and many more. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches for the advancement of the product, to stay competitive in the market. For instance, According to a report by Multidisciplinary Digital Publishing Institute in May 2020, colon cancers will be treated with nitric oxide synthase therapy.
The Report Covers
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Nitric Oxide Synthase Brain Market
• Recovery Scenario of Nitric Oxide Synthase Brain Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Abbexa Ltd.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Bio-Rad Laboratories, Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Enzo Life Sciences, Inc
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Boster Biological Technology
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Merck KGaA
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Nitric Oxide Synthase Brain Treatment Market by Type
4.1.1. Neuronal NOS (nNOS)
4.1.2. Endothelial NOS (eNOS)
4.1.3. Inducible NOS (iNOS)
4.2. Nitric Oxide Synthase Brain Treatment Market by End-User
4.2.1. Research Institute
4.2.2. Biotechnology
4.2.3. Pharmaceutical Company
4.2.4. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Boster Biological Technology
6.2. BioVision Inc.
6.3. Biorbyt Ltd.
6.4. Bioss Inc.
6.5. Enzo Life Sciences Inc.
6.6. Eli Lilly and Co
6.7. Lifespan BioSciences, Inc.
6.8. Neurophyxia BV
6.9. OriGene Technologies, Inc.
6.10. Proteintech Group, Inc.
6.11. QED Bioscience Inc.
6.12. Rockland Immunochemicals, Inc.
6.13. St John’s Laboratory Ltd.
1. GLOBAL NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2022 - 2028 ($ MILLION)
2. GLOBAL NNOS NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 - 2028 ($ MILLION)
3. GLOBAL ENOS NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 - 2028 ($ MILLION)
4. GLOBAL INOS NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 - 2028 ($ MILLION)
5. GLOBAL NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2028 ($ MILLION)
6. GLOBAL NITRIC OXIDE SYNTHASE BRAIN USED IN RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 - 2028 ($ MILLION)
7. GLOBAL NITRIC OXIDE SYNTHASE BRAIN USED IN BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 - 2028 ($ MILLION)
8. GLOBAL NITRIC OXIDE SYNTHASE BRAIN USED IN PHARMACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 - 2028 ($ MILLION)
9. GLOBAL NITRIC OXIDE SYNTHASE BRAIN USED IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 - 2028 ($ MILLION)
10. GLOBAL NITRIC OXIDE SYNTHASE BRAIN TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022 - 2028 ($ MILLION)
11. NORTH AMERICAN NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022 - 2028 ($ MILLION)
12. NORTH AMERICAN NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2022 - 2028 ($ MILLION)
13. NORTH AMERICAN NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS END-USER, 2022 - 2028 ($ MILLION)
14. EUROPEAN NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022 - 2028 ($ MILLION)
15. EUROPEAN NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2022 - 2028 ($ MILLION)
16. EUROPEAN NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 - 2028 ($ MILLION)
17. ASIA-PACIFIC NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022 - 2028 ($ MILLION)
18. ASIA-PACIFIC NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2022 - 2028 ($ MILLION)
19. ASIA-PACIFIC NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 - 2028 ($ MILLION)
20. REST OF THE WORLD NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022 - 2028 ($ MILLION)
21. REST OF THE WORLD NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2022 - 2028 ($ MILLION)
22. REST OF THE WORLD NITRIC OXIDE SYNTHASE BRAIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 - 2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL NITRIC OXIDE SYNTHASE BRAIN, 2021 - 2028($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL NITRIC OXIDE SYNTHASE BRAIN BY SEGMENT, 2021 - 2028($ MILLION)
3. RECOVERY OF GLOBAL NITRIC OXIDE SYNTHASE BRAIN, 2021-2027 (%)
4. GLOBAL NITRIC OXIDE SYNTHASE BRAIN SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL NNOS NITRIC OXIDE SYNTHASE BRAIN SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL ENOSNITRIC OXIDE SYNTHASE BRAIN SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL INOS OXIDE SYNTHASE BRAIN SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL NITRIC OXIDE SYNTHASE BRAIN SHARE BY END-USER, 2021 VS 2028 (%)
9. GLOBAL NITRIC OXIDE SYNTHASE BRAIN USED IN RESEARCH INSTITUTE SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL NITRIC OXIDE SYNTHASE BRAIN USED IN BIOTECHNOLOGY SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL NITRIC OXIDE SYNTHASE BRAIN USED IN PHARMACEUTICAL SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL NITRIC OXIDE SYNTHASE BRAIN USED IN OTHERS SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL NITRIC OXIDE SYNTHASE BRAIN SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. US GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
15. CANADA GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
16. UK GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
17. FRANCE GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
18. GERMANY GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
19. ITALY GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
20. SPAIN GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
21. REST OF EUROPE GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
22. INDIA GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
23. CHINA GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
24. JAPAN GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
25. REST OF ASIA-PACIFIC GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)
26. REST OF THE WORLD GLOBAL NITRIC OXIDE SYNTHASE BRAIN SIZE, 2021 - 2028($ MILLION)